European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
- PMID: 28792092
- DOI: 10.1111/jdv.14458
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
Abstract
The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, current strategies in the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum.
© 2017 European Academy of Dermatology and Venereology.
Comment in
-
Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis'.J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e84-e85. doi: 10.1111/jdv.14774. Epub 2018 Jan 23. J Eur Acad Dermatol Venereol. 2018. PMID: 29283443 No abstract available.
Similar articles
-
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.J Eur Acad Dermatol Venereol. 2024 Jul;38(7):1251-1280. doi: 10.1111/jdv.19912. Epub 2024 Mar 8. J Eur Acad Dermatol Venereol. 2024. PMID: 38456584 Review.
-
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1581-1594. doi: 10.1111/jdv.14466. Epub 2017 Aug 8. J Eur Acad Dermatol Venereol. 2017. PMID: 28786499
-
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.J Eur Acad Dermatol Venereol. 2024 Jul;38(7):1281-1299. doi: 10.1111/jdv.19937. Epub 2024 Mar 8. J Eur Acad Dermatol Venereol. 2024. PMID: 38456518 Review.
-
Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.Pediatr Clin North Am. 2018 Aug;65(4):757-781. doi: 10.1016/j.pcl.2018.04.002. Pediatr Clin North Am. 2018. PMID: 30031497 Review.
-
Systemic and localized scleroderma.Clin Dermatol. 2006 Sep-Oct;24(5):374-92. doi: 10.1016/j.clindermatol.2006.07.004. Clin Dermatol. 2006. PMID: 16966019 Review.
Cited by
-
Clinical and laboratory characterization of patients with localized scleroderma and response to UVA-1 phototherapy: In vivo and in vitro skin models.Photodermatol Photoimmunol Photomed. 2022 Nov;38(6):531-540. doi: 10.1111/phpp.12786. Epub 2022 Apr 3. Photodermatol Photoimmunol Photomed. 2022. PMID: 35324032 Free PMC article.
-
Association between quality of life and clinical characteristics in patients with morphea.Qual Life Res. 2018 Oct;27(10):2525-2532. doi: 10.1007/s11136-018-1897-1. Epub 2018 Jun 19. Qual Life Res. 2018. PMID: 29922914
-
Recurrent Seizures in a Case of Linear Scleroderma En Coup de Sabre.J Clin Neurol. 2024 Sep;20(5):545-547. doi: 10.3988/jcn.2024.0057. J Clin Neurol. 2024. PMID: 39227340 Free PMC article. No abstract available.
-
Morphea: The 2023 update.Front Med (Lausanne). 2023 Feb 13;10:1108623. doi: 10.3389/fmed.2023.1108623. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36860340 Free PMC article. Review.
-
Adult-onset en coup de sabre scleroderma in a patient with linear localized scleroderma profunda: A case report and literature review.SAGE Open Med Case Rep. 2021 Mar 19;9:2050313X21993304. doi: 10.1177/2050313X21993304. eCollection 2021. SAGE Open Med Case Rep. 2021. PMID: 33796311 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical